Background illustration for clinical trials search

Paid Clinical Trials Santa Monica

Discover 3,465 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Confronting Cancer as a Community

for
Colorectal Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT06063928

Recruiting

Predictive Validity of Acoustic Gastrointestinal Surveillance (AGIS) in Post-Operative Feeding

for
Post Operative Ileus
Location: Los Angeles CA
Sponsor: VA Greater Los Angeles Healthcare System

Sex: All

Age: 18+

Code: NCT02065583

Recruiting

Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy

for
Cytokine Release Syndrome
Location: Orange CA, Seattle WA, Augusta GA, Pittsburgh PA,
Sponsor: CytoAgents, Inc.

Sex: All

Age: 18+

Code: NCT05905328

Phase1, Phase2, Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: Beverly Hills CA, Los Angeles CA, Torrance CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

for
SLE (Systemic Lupus), RA - Rheumatoid Arthritis
Location: Beverly Hills CA, Tujunga CA, Monterey Park CA,
Sponsor: Neutrolis

Sex: All

Age: 18 - 70+

Code: NCT07237659

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Los Angeles CA, Palo Alto CA, Phoenix AZ, Scottsdale AZ,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06878261

Phase3, Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Lancaster CA, Ogden UT, Colorado Springs CO,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Sex: All

Age: 18 - 70+

Code: NCT06226883

Phase2, Recruiting

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

for
AML, Adult, MDS
Location: Duarte CA, Aurora CO, Houston TX, St Louis MO,
Sponsor: Stelexis BioSciences

Sex: All

Age: 18+

Code: NCT06533761

Phase1, Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Duarte CA, Irvine CA, Henderson NV, Palo Alto CA,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06588478

Phase2, Recruiting

Telehealth-delivered HealthcaRe to ImproVe Care

for
Telemedicine
Location: Beverly Hills CA
Sponsor: Attune Health Research, Inc.

Sex: All

Age: 19+

Code: NCT05483855

Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,
Location: Los Angeles CA, Ventura CA, Chandler AZ, Tucson AZ,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Beverly Hills CA, Pasadena CA, Phoenix AZ, Aurora CO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Beverly Hills CA, Los Angeles CA, Los Alamitos CA,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 16+

Code: NCT06617325

Phase3, Recruiting

Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction

for
Breast Cancer,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: Female

Age: 22 - 70+

Code: NCT05190978

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

for
Hypoxic-Ischemic Encephalopathy
Location: Orange CA, San Diego CA, Fort Worth TX, Little Rock AR,
Sponsor: ReAlta Life Sciences, Inc.

Sex: All

Age: 0

Code: NCT05778188

Phase2, Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

for
Primary Immune Thrombocytopenia (ITP)
Location: Los Angeles CA, Oceanside CA, Phoenix AZ, Aurora CO,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06544499

Phase3, Recruiting

Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

for
Inguinal Hernia, Postoperative Pain
Location: Laguna Hills CA, El Paso TX, Plano TX,
Sponsor: Innocoll

Sex: All

Age: 2 - 16

Code: NCT03262688

Phase3, Recruiting

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

for
Hepatocellular Carcinoma, Biliary Tract Cancer
Location: Beverly Hills CA, La Jolla CA, Houston TX,
Sponsor: Replimune Inc.

Sex: All

Age: 18+

Code: NCT05733598

Phase2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Beverly Hills CA, Los Angeles CA, Tarzana CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Beverly Hills CA, Fountain Valley CA, Bullhead City AZ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase3, Recruiting